Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06625047 · ClinicalTrials.gov registry record · Phase 4
Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy
A Phase 4 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT06625047: Completed Phase 4 study, sponsored by Mayo Clinic.
NCT06625047 is a Phase 4 study that has completed, run by Mayo Clinic. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06625047, a Phase 4 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
This phase IV trial compares patient satisfaction with telehealth versus in-person neuro-oncology assessments among glioma patients receiving oral chemotherapy. Gliomas are the most common primary central nervous system cancer and are associated with a high symptom burden, such as drowsiness, fatigue, memory difficulty, and difficulty communicating. Care at a high volume center is associated with an overall survival benefit, however, many patients may have physical or financial difficulties preventing access to these centers. Telehealth visits use computers, cameras, videoconferencing, the internet, satellite, and wireless communications to deliver healthcare, while in-person visits require the interaction to take place in the physical presence of someone else. Telehealth neuro-oncology assessments may be preferable compared to in-person assessments in glioma patients receiving oral chemotherapy.
Interventions
- OTHER Questionnaire Administration
- DRUG Temozolomide
- BEHAVIORAL Assessment
- OTHER Telemedicine Visit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-10-07 |
| Est. Completion | 2025-11-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06625047
The ClinicalTrials.gov registry entry for NCT06625047 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Questionnaire Administration is the first listed.
NCT06625047 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06625047 about?
NCT06625047 is a clinical study titled "Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy". This phase IV trial compares patient satisfaction with telehealth versus in-person neuro-oncology assessments among glioma patients receiving oral chemotherapy. Gliomas are the most common primary central nervous system cancer and are associated with a high symptom burden, such as drowsiness, fatigu...
What is the current status of trial NCT06625047?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2024-10-07. Estimated completion is 2025-11-12.
What interventions are being tested in trial NCT06625047?
The interventions under investigation include: Questionnaire Administration (OTHER), Temozolomide (DRUG), Assessment (BEHAVIORAL), Telemedicine Visit (OTHER).
Who is sponsoring clinical trial NCT06625047?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.